Browse Pet Safety Reports
18,045 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 18,045 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 18,045 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jun 16, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 16, 2025 | Horse | Morgan | Pergolide Mesylate | Fever; Elevated liver enzymes NOS | Outcome Unknown |
| Jun 15, 2025 | Horse | Quarter Horse | Hyaluronate Sodium | Seizure NOS; Death by euthanasia; Behavioural disorder NOS | Euthanized |
| Jun 15, 2025 | Horse | Oldenburg | Enrofloxacin | Seizure NOS; Death by euthanasia; Lying down | Euthanized |
| Jun 15, 2025 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Pruritus; Hives (see also Skin); Tachycardia; Hypersensitivity NOS | Recovered/Normal |
| Jun 13, 2025 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Injection site swelling | Recovered/Normal |
| Jun 13, 2025 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 13, 2025 | Horse | Quarter Horse | Ivermectin; Praziquantel | Chemical burn; Oral swelling | Recovered/Normal |
| Jun 12, 2025 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 12, 2025 | Horse | Horse (unknown) | Hyaluronate Sodium | Injection site inflammation | Outcome Unknown |
| Jun 11, 2025 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 11, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 11, 2025 | Horse | Westphalian | Omeprazole | Behavioural disorder NOS | Outcome Unknown |
| Jun 10, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 10, 2025 | Horse | Quarter Horse, Horse (other) | Ceftiofur Crystalline Free Acid | Lack of efficacy - NOS; Intentional misuse | Ongoing |
| Jun 10, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 9, 2025 | Horse | Pony of the Americas | Ivermectin | Lack of efficacy - NOS; Death by euthanasia | Euthanized |
| Jun 8, 2025 | Horse | Horse (unknown) | Pergolide Mesylate | Nasal bleeding | Outcome Unknown |
| Jun 8, 2025 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Collapse (see also Cardio-vascular and Systemic disorders); Dyspnoea; Hives (... | Euthanized |
| Jun 7, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 7, 2025 | Horse | Horse (other) | Pentosan Polysulfate Sodium | Injection site swelling; Abnormal serum protein NOS | Outcome Unknown |
| Jun 6, 2025 | Horse | Horse (other) | Omeprazole | INEFFECTIVE, GASTRIC ULCER(S) | Outcome Unknown |
| Jun 6, 2025 | Horse | Friesian | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 6, 2025 | Horse | Unknown | Sodium Hyaluronate | Joint swelling | Outcome Unknown |
| Jun 6, 2025 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 6, 2025 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 6, 2025 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 5, 2025 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 5, 2025 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 5, 2025 | Horse | Warmblood - Dutch, Warmbloo... | Ketamine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Jun 5, 2025 | Horse | Morgan | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 5, 2025 | Horse | Hanovarian | Diclazuril Oral Pellets | Gastric ulcer; Hives (see also Skin); Skin disorders NOS; Weight loss; Off fo... | Ongoing |
| Jun 5, 2025 | Horse | Quarter Horse | Methylprednisolone Acetate | Collapse (see also Cardio-vascular and Systemic disorders); Pale mucous membr... | Died |
| Jun 5, 2025 | Horse | Quarter Horse | Butorphanol Injectable | Collapse (see also Cardio-vascular and Systemic disorders); Pale mucous membr... | Died |
| Jun 5, 2025 | Horse | Crossbred Equine/horse, Qua... | Diclazuril Oral Pellets | Lack of efficacy (protozoa) - NOS; Death by euthanasia | Euthanized |
| Jun 5, 2025 | Horse | Horse (unknown) | Xylazine Hydrochloride | Death | Died |
| Jun 5, 2025 | Horse | Quarter Horse | Methylprednisolone Acetate | Collapse (see also Cardio-vascular and Systemic disorders); Pale mucous membr... | Died |
| Jun 5, 2025 | Horse | Quarter Horse | Butorphanol Tartrate Injection | Anaphylaxis; Ataxia; Collapse (see also Cardio-vascular and Systemic disorder... | Died |
| Jun 5, 2025 | Horse | Quarter Horse | Butorphanol Injectable | Collapse (see also Cardio-vascular and Systemic disorders); Pale mucous membr... | Died |
| Jun 5, 2025 | Horse | Quarter Horse | Methylprednisolone Acetate | Anaphylaxis; Ataxia; Collapse (see also Cardio-vascular and Systemic disorder... | Died |
| Jun 4, 2025 | Horse | Unknown | Flunixin Meglumine | Anaphylactoid reaction | Recovered/Normal |
| Jun 3, 2025 | Horse | Hanovarian | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 3, 2025 | Horse | Horse (unknown) | Hyaluronate Sodium | Injection site pain | Outcome Unknown |
| Jun 2, 2025 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Rolling; Behavioural disorder NOS; Colic; Aggression; Biting -aggression (see... | Recovered/Normal |
| Jun 2, 2025 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 2, 2025 | Horse | Horse (unknown) | Pergolide Mesylate | Depression; Not eating; Behavioural disorder NOS | Recovered/Normal |
| Jun 1, 2025 | Horse | Missouri Fox Trotting Horse | Pentosan Polysulfate Sodium | Laminitis | Outcome Unknown |
| Jun 1, 2025 | Horse | Horse (unknown) | Butorphanol Tartrate | Sedation prolonged; Hives (see also Skin) | Recovered/Normal |
| May 29, 2025 | Horse | Unknown | Hyaluronate Sodium | Colic | Outcome Unknown |
| May 28, 2025 | Horse | Tennessee Walking Horse | Omeprazole | Colic; Rolling; Sternoabdominal recumbency; Death by euthanasia | Euthanized |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.